<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02361736</url>
  </required_header>
  <id_info>
    <org_study_id>IRB2014-102-01</org_study_id>
    <nct_id>NCT02361736</nct_id>
  </id_info>
  <brief_title>Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients During Orthopaedic Surgery</brief_title>
  <official_title>Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yuanyuan Zhang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tianjin Union Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin First Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tianjin Medical University General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hydroxyethyl starch (HES) is commonly used as plasma expander during surgery but may be
      nephrotoxic as seen in studies in patients with sepsis. The investigators hypothesized that
      the possible nephrotoxicity of 6% HES 130/0.4 could be revealed by measurements of urinary
      and plasma neutrophil gelatinase-associated lipocalin and interleukin-18 (IL-18) in old
      patients with normal renal function during orthopaedic surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hydroxyethyl starch (HES) is widely used as volume expander to maintain circulation in
      patients during surgery, trauma, and in critical disease, where a rapid and sustained volume
      expansion is the goal. However, acute kidney injury (AKI) is sometimes a complication in
      these patients and HES might be a contributing factor. Acute kidney injury is often diagnosed
      using a sudden rise in plasma creatinine (p-crea) or an abrupt decrease in urine output.
      P-crea depends on sex, nutrition, medication,muscle mass, and age and it increases 24 to 48 h
      after renal injury, so the diagnosis of AKI is delayed when using p-crea alone as an
      indicator for renal damage. New technology allows for earlier diagnosis of AKI using
      measurements of biomarkers in urine. Neutrophil gelatinase-associated lipocalin (NGAL) is a
      small protein, which is filtered via the glomeruli and reabsorbed in the proximal tubules,
      and thus low concentrations of NGAL can be measured in the blood and urine. Approximately 6 h
      after a renal injury, NGAL increases rapidly due to an up-regulated expression and secretion
      in the epithelial cells of the thick ascending limb of Henle's loop, the distal tubules, and
      the collecting ducts. Thus, NGAL can be used as a marker of renal damage. However, infections
      and malignancies can give falsely increased levels.

      Interleukin-18 (IL-18) is mainly created from proximal kidney tubules which is a
      proinflammatory factor that can be detected in earlier urine of AKI animal models. There is
      significant rise in IL-18 levels in urine of AKI confirmed cases(no chronic kidney disease,
      no urinary tract infections, no prerenal factors), specificity and susceptibility is 90%. As
      a result, IL-18 can be selected as a biomarker.

      Intravenously administrated HES is excreted in urine but is also partly accumulated in the
      tissues. Studies in animals and humans showed that HES molecules were accumulated in the
      proximal tubule cells with subsequent vacuolization and swelling—a condition known as osmotic
      nephrosis. However, recent studies, primarily conducted in patients with sepsis, found
      impaired renal function even when using tetrastarch. In contrast, perioperative studies found
      no evidence of AKI after infusion of HES. The investigators hypothesized that 6% HES 130/0.4
      had a nephrotoxic effect, which could be revealed by measurements of urinary and plasma NGAL
      and IL-18; that 6% HES 130/0.4 influenced kidney function differently than
      crystalloids(lactated Ringer's solution) due to the different pharmacokinetic properties of
      colloids compared with that of crystalloids.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concentration of NGAL in Urine on 5 Time Point</measure>
    <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
    <description>Neutrophil gelatinase-associated lipocalin (NGAL) is a small protein, which is filtered via the glomeruli and reabsorbed in the proximal tubules, and thus low concentrations of NGAL can be measured in the blood and urine.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of IL-18 in Urine on 5 Time Point</measure>
    <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
    <description>IL-18 is mainly created from proximal kidney tubules which is a proinflammatory factor that can be detected in earlier urine of AKI animal models.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of IL-18 in Plasma on 5 Time Point</measure>
    <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of NGAL in Plasma on 5 Time Point.</measure>
    <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
    <description>concentration of NGAL in plasma on 5 time point. Biomarkers are measured by ELISA.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concentration of β2 Microglobulin in Urine</measure>
    <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated Glomerular Filtration Rate(eGFR) on 5 Time Point</measure>
    <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
    <description>eGFR is calculated by concentration of creatinine and CKD-EPI2009</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of the Urine Trace Albumin and Creatinine(ACR) on 5 Time Point</measure>
    <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
    <description>ACR is calculated by the urine trace albumin divided by the urine creatinine</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Total Fluid Volume Increased</condition>
  <arm_group>
    <arm_group_label>Lactate Ringers</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydroxyethyl Starch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6% Hydroxyethyl Starch (HES) is intravenously administrated at a dose of 7.5ml/ kg in the first hour of surgery, and then, Lactate Ringers' is administrated to the patient until the end of the surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxyethyl Starch</intervention_name>
    <description>6% Hydroxyethyl Starch(HES) is intravenously given 7.5ml/kg for the first hour of surgery</description>
    <arm_group_label>Hydroxyethyl Starch</arm_group_label>
    <other_name>HES</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactate Ringers</intervention_name>
    <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
    <arm_group_label>Lactate Ringers</arm_group_label>
    <other_name>LR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Old patients scheduled to undergo orthopaedic surgery under a intravertebral
             anesthesia. (American Society of Anesthesiologists physical status I-Ⅲ)

        Exclusion Criteria:

          -  Allergy and contraindication to HES

          -  Infections and malignancies

          -  Sepsis

          -  History of heart failure or New York Heart Association(NYHA)＞Ⅲ

          -  Renal failure or Cr&gt;108μmol/L，BUN&gt;8.3mmol/L

          -  Undergoing dialytic treatments

          -  Intracranial hemorrhages

          -  Taking non-steroidal antiinflammatory agent for a long time

          -  Inability to understand the Study Information Sheet and provide a written consent to
             take part in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu Yonghao, M.D.,Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tianjin Medical University General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tianjin Medical University General Hospital</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <zip>300052</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2015</study_first_submitted>
  <study_first_submitted_qc>February 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2015</study_first_posted>
  <results_first_submitted>January 25, 2016</results_first_submitted>
  <results_first_submitted_qc>February 23, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 24, 2016</results_first_posted>
  <last_update_submitted>February 23, 2016</last_update_submitted>
  <last_update_submitted_qc>February 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tianjin Medical University General Hospital</investigator_affiliation>
    <investigator_full_name>Yuanyuan Zhang</investigator_full_name>
    <investigator_title>Tianjin Medical University General Hospital Ethics Committee</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>From February 2015 to January 2016, patients were recruited and estimated for eligibility.</recruitment_details>
      <pre_assignment_details>Exclusion criteria:Allergy and contraindication to HES; Infections and malignancies; Sepsis; History of heart failure or NYHA＞Ⅲ; Renal failure or Cr&gt;108μmol/L，BUN&gt;8.3mmol/L;Undergoing dialytic treatments; Intracranial hemorrhages;Taking non-steroidal antiinflammatory agent for a long time</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Lactate Ringers</title>
          <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery
Lactate Ringers: Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
        </group>
        <group group_id="P2">
          <title>Hydroxyethyl Starch</title>
          <description>6% Hydroxyethyl Starch (HES) is intravenously administrated at a dose of 7.5ml/ kg in the first hour of surgery, and then, Lactate Ringers’ is administrated to the patient until the end of the surgery
Hydroxyethyl Starch: 6% Hydroxyethyl Starch(HES) is intravenously given 7.5ml/kg for the first hour of surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Ages Eligible for Study: ≥65 Years； Both Genders；No Healthy Volunteers</population>
      <group_list>
        <group group_id="B1">
          <title>Lactate Ringers</title>
          <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery
Lactate Ringers: Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
        </group>
        <group group_id="B2">
          <title>Hydroxyethyl Starch</title>
          <description>6% Hydroxyethyl Starch (HES) is intravenously administrated at a dose of 7.5ml/ kg in the first hour of surgery, and then, Lactate Ringers’ is administrated to the patient until the end of the surgery
Hydroxyethyl Starch: 6% Hydroxyethyl Starch(HES) is intravenously given 7.5ml/kg for the first hour of surgery</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="59"/>
            <count group_id="B2" value="59"/>
            <count group_id="B3" value="118"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>age</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76.4" spread="8.1"/>
                    <measurement group_id="B2" value="75.9" spread="7.5"/>
                    <measurement group_id="B3" value="76.2" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Concentration of NGAL in Urine on 5 Time Point</title>
        <description>Neutrophil gelatinase–associated lipocalin (NGAL) is a small protein, which is filtered via the glomeruli and reabsorbed in the proximal tubules, and thus low concentrations of NGAL can be measured in the blood and urine.</description>
        <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactate Ringers</title>
            <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery
Lactate Ringers: Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
          </group>
          <group group_id="O2">
            <title>Hydroxyethyl Starch</title>
            <description>6% Hydroxyethyl Starch (HES) is intravenously administrated at a dose of 7.5ml/ kg in the first hour of surgery, and then, Lactate Ringers’ is administrated to the patient until the end of the surgery
Hydroxyethyl Starch: 6% Hydroxyethyl Starch(HES) is intravenously given 7.5ml/kg for the first hour of surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Concentration of NGAL in Urine on 5 Time Point</title>
          <description>Neutrophil gelatinase–associated lipocalin (NGAL) is a small protein, which is filtered via the glomeruli and reabsorbed in the proximal tubules, and thus low concentrations of NGAL can be measured in the blood and urine.</description>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>-1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="0.7"/>
                    <measurement group_id="O2" value="4.9" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" spread="0.4"/>
                    <measurement group_id="O2" value="5.1" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="0.3"/>
                    <measurement group_id="O2" value="4.9" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="0.3"/>
                    <measurement group_id="O2" value="5.2" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="0.8"/>
                    <measurement group_id="O2" value="5.1" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Concentration of IL-18 in Urine on 5 Time Point</title>
        <description>IL-18 is mainly created from proximal kidney tubules which is a proinflammatory factor that can be detected in earlier urine of AKI animal models.</description>
        <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactate Ringers</title>
            <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery
Lactate Ringers: Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
          </group>
          <group group_id="O2">
            <title>Hydroxyethyl Starch</title>
            <description>6% Hydroxyethyl Starch (HES) is intravenously administrated at a dose of 7.5ml/ kg in the first hour of surgery, and then, Lactate Ringers’ is administrated to the patient until the end of the surgery
Hydroxyethyl Starch: 6% Hydroxyethyl Starch(HES) is intravenously given 7.5ml/kg for the first hour of surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Concentration of IL-18 in Urine on 5 Time Point</title>
          <description>IL-18 is mainly created from proximal kidney tubules which is a proinflammatory factor that can be detected in earlier urine of AKI animal models.</description>
          <units>μg/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>-1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.6" spread="8.5"/>
                    <measurement group_id="O2" value="82.7" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.2" spread="4.8"/>
                    <measurement group_id="O2" value="89.5" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118.5" spread="11.4"/>
                    <measurement group_id="O2" value="109.6" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="142.6" spread="18.1"/>
                    <measurement group_id="O2" value="140.5" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="162.0" spread="18.5"/>
                    <measurement group_id="O2" value="159.7" spread="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Concentration of IL-18 in Plasma on 5 Time Point</title>
        <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactate Ringers</title>
            <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery
Lactate Ringers: Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
          </group>
          <group group_id="O2">
            <title>Hydroxyethyl Starch</title>
            <description>6% Hydroxyethyl Starch (HES) is intravenously administrated at a dose of 7.5ml/ kg in the first hour of surgery, and then, Lactate Ringers’ is administrated to the patient until the end of the surgery
Hydroxyethyl Starch: 6% Hydroxyethyl Starch(HES) is intravenously given 7.5ml/kg for the first hour of surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Concentration of IL-18 in Plasma on 5 Time Point</title>
          <units>μg/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>-1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.0" spread="14.5"/>
                    <measurement group_id="O2" value="79.3" spread="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.4" spread="9.0"/>
                    <measurement group_id="O2" value="81.0" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.8" spread="12.5"/>
                    <measurement group_id="O2" value="84.2" spread="13.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.5" spread="14.1"/>
                    <measurement group_id="O2" value="83.4" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.5" spread="6.1"/>
                    <measurement group_id="O2" value="85.1" spread="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Concentration of β2 Microglobulin in Urine</title>
        <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactate Ringers</title>
            <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery
Lactate Ringers: Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
          </group>
          <group group_id="O2">
            <title>Hydroxyethyl Starch</title>
            <description>6% Hydroxyethyl Starch (HES) is intravenously administrated at a dose of 7.5ml/ kg in the first hour of surgery, and then, Lactate Ringers’ is administrated to the patient until the end of the surgery
Hydroxyethyl Starch: 6% Hydroxyethyl Starch(HES) is intravenously given 7.5ml/kg for the first hour of surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Concentration of β2 Microglobulin in Urine</title>
          <units>mg/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>-1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.2" spread="8.9"/>
                    <measurement group_id="O2" value="96.4" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.6" spread="8.2"/>
                    <measurement group_id="O2" value="97.1" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.8" spread="14.2"/>
                    <measurement group_id="O2" value="101.7" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104.7" spread="15.0"/>
                    <measurement group_id="O2" value="99.4" spread="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.2" spread="12.3"/>
                    <measurement group_id="O2" value="103.0" spread="13.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estimated Glomerular Filtration Rate(eGFR) on 5 Time Point</title>
        <description>eGFR is calculated by concentration of creatinine and CKD-EPI2009</description>
        <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactate Ringers</title>
            <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery
Lactate Ringers: Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
          </group>
          <group group_id="O2">
            <title>Hydroxyethyl Starch</title>
            <description>6% Hydroxyethyl Starch (HES) is intravenously administrated at a dose of 7.5ml/ kg in the first hour of surgery, and then, Lactate Ringers’ is administrated to the patient until the end of the surgery
Hydroxyethyl Starch: 6% Hydroxyethyl Starch(HES) is intravenously given 7.5ml/kg for the first hour of surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Glomerular Filtration Rate(eGFR) on 5 Time Point</title>
          <description>eGFR is calculated by concentration of creatinine and CKD-EPI2009</description>
          <units>mL/min/1.73m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>-1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.9" spread="8.3"/>
                    <measurement group_id="O2" value="63.9" spread="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.5" spread="9.6"/>
                    <measurement group_id="O2" value="63.5" spread="13.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.0" spread="6.2"/>
                    <measurement group_id="O2" value="64.0" spread="14.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.0" spread="9.4"/>
                    <measurement group_id="O2" value="72.8" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.4" spread="9.2"/>
                    <measurement group_id="O2" value="68.6" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Concentration of NGAL in Plasma on 5 Time Point.</title>
        <description>concentration of NGAL in plasma on 5 time point. Biomarkers are measured by ELISA.</description>
        <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactate Ringers</title>
            <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery
Lactate Ringers: Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
          </group>
          <group group_id="O2">
            <title>Hydroxyethyl Starch</title>
            <description>6% Hydroxyethyl Starch (HES) is intravenously administrated at a dose of 7.5ml/ kg in the first hour of surgery, and then, Lactate Ringers’ is administrated to the patient until the end of the surgery
Hydroxyethyl Starch: 6% Hydroxyethyl Starch(HES) is intravenously given 7.5ml/kg for the first hour of surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Concentration of NGAL in Plasma on 5 Time Point.</title>
          <description>concentration of NGAL in plasma on 5 time point. Biomarkers are measured by ELISA.</description>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>-1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="0.8"/>
                    <measurement group_id="O2" value="4.0" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="0.7"/>
                    <measurement group_id="O2" value="4.2" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" spread="0.9"/>
                    <measurement group_id="O2" value="4.3" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="0.7"/>
                    <measurement group_id="O2" value="4.2" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="0.8"/>
                    <measurement group_id="O2" value="4.4" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ratio of the Urine Trace Albumin and Creatinine(ACR) on 5 Time Point</title>
        <description>ACR is calculated by the urine trace albumin divided by the urine creatinine</description>
        <time_frame>-1d, 0d, 1d, 3d, 5d after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Lactate Ringers</title>
            <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery
Lactate Ringers: Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
          </group>
          <group group_id="O2">
            <title>Hydroxyethyl Starch</title>
            <description>6% Hydroxyethyl Starch (HES) is intravenously administrated at a dose of 7.5ml/ kg in the first hour of surgery, and then, Lactate Ringers’ is administrated to the patient until the end of the surgery
Hydroxyethyl Starch: 6% Hydroxyethyl Starch(HES) is intravenously given 7.5ml/kg for the first hour of surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Ratio of the Urine Trace Albumin and Creatinine(ACR) on 5 Time Point</title>
          <description>ACR is calculated by the urine trace albumin divided by the urine creatinine</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>-1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.89" spread="0.14"/>
                    <measurement group_id="O2" value="1.96" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.84" spread="0.20"/>
                    <measurement group_id="O2" value="1.98" spread="0.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.90" spread="0.19"/>
                    <measurement group_id="O2" value="1.90" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.94" spread="0.15"/>
                    <measurement group_id="O2" value="1.99" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5d</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.92" spread="0.12"/>
                    <measurement group_id="O2" value="1.95" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Lactate Ringers</title>
          <description>Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery
Lactate Ringers: Lactate Ringers is intravenously administrated at a dose of 7.5ml/kg during the surgery</description>
        </group>
        <group group_id="E2">
          <title>Hydroxyethyl Starch</title>
          <description>6% Hydroxyethyl Starch (HES) is intravenously administrated at a dose of 7.5ml/ kg in the first hour of surgery, and then, Lactate Ringers’ is administrated to the patient until the end of the surgery
Hydroxyethyl Starch: 6% Hydroxyethyl Starch(HES) is intravenously given 7.5ml/kg for the first hour of surgery</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>We may have to prolong the follow-up visit for patients.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Yuanyuan Zhang</name_or_title>
      <organization>Tianjin Medical University General Hospital</organization>
      <phone>13821685913</phone>
      <email>doctorkelly@126.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

